List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 2368 studies with search of:   United States, District of Columbia
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: insulin detemir
2 Recruiting The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-Term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs.
Condition: HIV-1
Intervention: Drug: TMC125
3 Enrolling by invitation Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities
Condition: Stroke
Intervention:
4 Completed Tipranavir/Ritonavir (TPV/r) in Protease Inhibitor (PI)-Experienced Patients With HIV-1 Infection
Condition: HIV Infection
Intervention: Drug: Tipranavir co-administered with low dose ritonavir
5 Completed A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides
Conditions: Pneumonia, Pneumocystis Carinii;   HIV Infections
Interventions: Drug: Atovaquone;   Drug: Dapsone
6 Completed A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Zalcitabine;   Drug: Didanosine
7 Completed The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients
Conditions: Mycobacterium Avium-Intracellulare Infection;   HIV Infections
Interventions: Drug: Clarithromycin;   Drug: Rifabutin
8 Active, not recruiting An International Study to Evaluate Anti-HIV Therapy Plus Interleukin-2 (rIL-2) in HIV Positive Patients
Condition: HIV Infections
Intervention: Drug: Aldesleukin
9 Completed A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: Zidovudine;   Drug: Zalcitabine;   Drug: Didanosine
10 Active, not recruiting Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery with Cardio-Pulmonary Bypass
Conditions: Cardio-pulmonary Bypass;   Coronary Artery Bypass Graft
Intervention: Drug: pexelizumab
11 Recruiting Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bevacizumab;   Drug: cyclophosphamide;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: placebo
12 Recruiting Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)
Condition: HIV Infection
Interventions: Drug: Elvitegravir;   Drug: Raltegravir
13 Active, not recruiting Tretinoin, Cytarabine, and Daunorubicin With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia
Condition: Leukemia
Interventions: Drug: arsenic trioxide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: tretinoin
14 Completed Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Isoniazid;   Drug: Pyrazinamide;   Drug: Pyridoxine hydrochloride;   Drug: Rifampin
15 Completed Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: Zidovudine;   Drug: Didanosine
16 Active, not recruiting Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
Condition: HIV Infection
Interventions: Drug: ABC/3TC + ATV/r x 36wks followed by ABC/3TC + ATV x 48wks;   Drug: ABC/3TC + ATV/r x 36wks followed by ABC/3TC + ATV/r x 48wks
17 Completed Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: fluorouracil;   Drug: leucovorin calcium;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: radiation therapy
18 Active, not recruiting A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Ritonavir;   Drug: Nelfinavir mesylate
19 Completed A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine
Condition: HIV Infections
Intervention: Drug: Didanosine
20 Active, not recruiting Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
Condition: Leukemia
Interventions: Drug: cyclophosphamide;   Drug: fludarabine phosphate

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services